BioProduction Systems

Pre-clinical

Bay Area, United StatesFounded 2010bioproductionsystems.com

BioProduction Systems is a specialized CDMO focused on empowering biotechnology through innovation, offering end-to-end services from process development to commercial manufacturing. The company leverages expertise in CHO cells, microbial expression (notably E. coli secretion), and advanced analytics to deliver high-quality biologics. Guided by principles of transparency and collaboration, it provides clients with real-time data access and process insights, positioning itself as a strategic partner in the biomanufacturing ecosystem, particularly within the Bay Area.

Founded

2010

Focus

BiologicsCell Therapy

AI Company Overview

Technology Platform

A CDMO platform specializing in microbial (E. coli secretion) and mammalian (CHO) expression systems, offering integrated process development, scale-up, GMP manufacturing, and data analytics services for biologic production.

Funding History

Total raised: $13.8M

Series A$12MSOSVOct 15, 2021

Seed$1.8MUndisclosedMay 15, 2019

Opportunities

Growth is driven by the strong outsourcing trend in pharma, increasing demand for complex biologics like bispecifics, and its strategic location in the biotech-rich Bay Area.

The company's niche in E.

coli secretion and emphasis on data transparency present opportunities to attract clients seeking specialized, collaborative partners.

Risk Factors

Key risks include intense competition from larger global CDMOs, dependence on the biotech funding cycle, client concentration risk, and the capital-intensive nature of maintaining and scaling GMP manufacturing facilities.

Regulatory execution risk on behalf of clients is also a constant concern.

Competitive Landscape

Competes against large global CDMOs (Lonza, WuXi Biologics) and mid-size specialists (AGC Biologics, Avid). Differentiates through technical expertise in E. coli secretion for antibody fragments, a strong collaborative and transparent partnership model, and a focused commitment to the Bay Area biotech ecosystem.